We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Blackbaud
BLKB
$1.5B
| $333K | ﹤0.01% |
5,021
+165
| +3% | +$11.2K |
|
1452
NewMarket
NEU
$7.17B
| $333K | ﹤0.01% |
775
-6
| -0.8% | -$2.55K |
|
1453
CNX Resources
CNX
$4.85B
| $332K | ﹤0.01% |
20,777
-4,526
| -18% | -$66.8K |
|
1454
FMC
FMC
$1.42B
| $331K | ﹤0.01% |
7,895
+1,072
| +16% | +$44.2K |
|
1455
Piper Sandler
PIPR
$5.14B
| $331K | ﹤0.01% |
27,388
-3,556
| -11% | -$38.7K |
|
1456
Enova International
ENVA
$5.91B
| $329K | ﹤0.01% |
33,977
-3,872
| -10% | -$34.6K |
|
|
RDS.B
1457
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $327K | ﹤0.01% |
6,198
+213
| +4% | +$11.4K |
|
|
CIR
1458
DELISTED
CIRCOR International, Inc
CIR
| $325K | ﹤0.01% |
5,453
+221
| +4% | +$13K |
|
|
CRAY
1459
DELISTED
Cray, Inc.
CRAY
| $325K | ﹤0.01% |
13,788
+3,196
| +30% | +$81.5K |
|
1460
Bio-Rad Laboratories Class A
BIO
$8.42B
| $324K | ﹤0.01% |
1,980
-78
| -4% | -$11.8K |
|
|
SWC
1461
DELISTED
Stillwater Mining Co
SWC
| $324K | ﹤0.01% |
24,268
-4,849
| -17% | -$65.1K |
|
1462
Dine Brands
DIN
$432M
| $322K | ﹤0.01% |
4,063
+214
| +6% | +$17K |
|
1463
Woodward
WWD
$25B
| $322K | ﹤0.01% |
5,157
+32
| +0.6% | +$1.93K |
|
1464
Northwest Natural Holdings
NWN
$2.17B
| $320K | ﹤0.01% |
5,325
-638
| -11% | -$39.9K |
|
1465
Universal Insurance Holdings
UVE
$1.16B
| $320K | ﹤0.01% |
12,693
-2,401
| -16% | -$53.9K |
|
|
VAR
1466
DELISTED
Varian Medical Systems, Inc.
VAR
| $319K | ﹤0.01% |
3,653
-201
| -5% | -$16.4K |
|
1467
EXL Service
EXLS
$4.23B
| $318K | ﹤0.01% |
31,920
-2,165,220
| -99% | -$22M |
|
1468
Carpenter Technology
CRS
$30B
| $317K | ﹤0.01% |
7,674
-694
| -8% | -$26.2K |
|
1469
H&R Block
HRB
$5.18B
| $317K | ﹤0.01% |
13,678
+1,452
| +12% | +$34K |
|
1470
Rogers Corp
ROG
$2.33B
| $317K | ﹤0.01% |
5,187
+504
| +11% | +$30.6K |
|
1471
Universal Electronics
UEIC
$57.2M
| $317K | ﹤0.01% |
4,260
-219
| -5% | -$16.5K |
|
1472
Heartland Express
HTLD
$1.11B
| $316K | ﹤0.01% |
16,730
-1,617
| -9% | -$30.3K |
|
1473
Brown-Forman Class B
BF.B
$12B
| $315K | ﹤0.01% |
10,377
+1,033
| +11% | +$32.1K |
|
1474
UNIFI
UFI
$117M
| $315K | ﹤0.01% |
10,694
-1,285
| -11% | -$35K |
|
1475
Werner Enterprises
WERN
$2.54B
| $315K | ﹤0.01% |
13,543
+1,063
| +9% | +$25.2K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.